Most Popular
-
1
Opposition-led Assembly unilaterally passes bill to probe Marine's death
-
2
Inflation eases in April, continues bumpy ride
-
3
Russia sent more than 165,000 barrels of refined petroleum to N. Korea in March: White House
-
4
Key suspects grilled over alleged abuse of power in Marine death inquiry
-
5
Seoul alerts overseas missions to NK terror threats
-
6
‘Inside Out 2’ adds four new emotions, explores teenage life
-
7
[Graphic News] Number of coffee franchises in S. Korea rises 13%
![[Graphic News] Number of coffee franchises in S. Korea rises 13%](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/02/20240502050817_0.gif&u=)
-
8
S. Korean children, teens grow taller, mature faster than before: study
-
9
Some junior doctors are returning: Health Ministry
-
10
Public backlash against division of Gyeonggi Province under 'corny' name
![[Graphic News] Number of coffee franchises in S. Korea rises 13%](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/02/20240502050817_0.gif&u=)
Multinational drug firms top list of approvals for clinical trials
By Paige ShinPublished : July 3, 2017 - 11:32
Multinational pharmaceutical companies have topped the list in winning approvals from South Korea's drug regulatory agency for clinical trials this year, data showed Monday.
According to the data by the Ministry of Food and Drug Safety, four major global drug manufacturers have won a combined 42 clinical trials during the first half of 2017.
According to the data by the Ministry of Food and Drug Safety, four major global drug manufacturers have won a combined 42 clinical trials during the first half of 2017.
Gilead Sciences Korea, the local unit of Gilead Sciences, won the approval of 13 clinical trials, followed by Novatis Korea with 11, Roche Korea with nine and MSD Korea with nine.
Industry officials attributed the global firms winning most of clinical trials to weaker research and development spending by local players.
Two drug firms -- Hanmi Pharmaceutical and Chong Kun Dang Pharmaceutical -- were the only two local South Korean companies topping the list by winning seven clinical trials each in the January-June period, the latest data showed. (Yonhap)
